BACKGROUND AND OBJECTIVE: The hamster cheek pouch carcinogenesis model, using chronic treatments of dimethylbenz[alpha]anthracene (DMBA) was used as a model system to investigate changes in epithelial tissue autofluorescence throughout the dysplasia-carcinoma sequence. STUDY DESIGN/ MATERIALS AND METHODS: Fluorescence emission spectra were measured weekly from 42 DMBA-treated animals and 20 control animals at 337, 380, and 460 nm excitation. A subset of data in which histopathology was available was used to develop diagnostic algorithms to separate neoplastic and non-neoplastic tissue. The change in fluorescence intensity over time was examined in all samples at excitation-emission wavelength pairs identified as diagnostically useful. RESULTS: Algorithms based on autofluorescence can separate neoplastic and non-neoplastic tissue with 95% sensitivity and 93% specificity. Greatest contributions to diagnostic algorithms are obtained at 380 nm excitation, and 430, 470, and 600 nm emission. Changes in fluorescence intensity are apparent as early as 3 weeks after initial treatment with DMBA, whereas morphologic changes associated with dysplasia occur on average at 7.5-12.5 weeks after initial treatment. CONCLUSIONS: Fluorescence spectroscopy provides a potential tool to identify biochemical changes associated with dysplasia and hyperplasia, which precede morphologic changes observed in histologically stained sections. Copyright 2001 Wiley-Liss, Inc.
BACKGROUND AND OBJECTIVE: The hamster cheek pouch carcinogenesis model, using chronic treatments of dimethylbenz[alpha]anthracene (DMBA) was used as a model system to investigate changes in epithelial tissue autofluorescence throughout the dysplasia-carcinoma sequence. STUDY DESIGN/ MATERIALS AND METHODS: Fluorescence emission spectra were measured weekly from 42 DMBA-treated animals and 20 control animals at 337, 380, and 460 nm excitation. A subset of data in which histopathology was available was used to develop diagnostic algorithms to separate neoplastic and non-neoplastic tissue. The change in fluorescence intensity over time was examined in all samples at excitation-emission wavelength pairs identified as diagnostically useful. RESULTS: Algorithms based on autofluorescence can separate neoplastic and non-neoplastic tissue with 95% sensitivity and 93% specificity. Greatest contributions to diagnostic algorithms are obtained at 380 nm excitation, and 430, 470, and 600 nm emission. Changes in fluorescence intensity are apparent as early as 3 weeks after initial treatment with DMBA, whereas morphologic changes associated with dysplasia occur on average at 7.5-12.5 weeks after initial treatment. CONCLUSIONS: Fluorescence spectroscopy provides a potential tool to identify biochemical changes associated with dysplasia and hyperplasia, which precede morphologic changes observed in histologically stained sections. Copyright 2001 Wiley-Liss, Inc.
Authors: Rebecca M Williams; Andrea Flesken-Nikitin; Lora Hedrick Ellenson; Denise C Connolly; Thomas C Hamilton; Alexander Yu Nikitin; Warren R Zipfel Journal: Transl Oncol Date: 2010-06-01 Impact factor: 4.243
Authors: D Gregory Farwell; Jeremy D Meier; Jesung Park; Yang Sun; Heather Coffman; Brian Poirier; Jennifer Phipps; Steve Tinling; Danny J Enepekides; Laura Marcu Journal: Arch Otolaryngol Head Neck Surg Date: 2010-02
Authors: Melissa C Skala; Gregory M Palmer; Changfang Zhu; Quan Liu; Kristin M Vrotsos; Crystal L Marshek-Stone; Annette Gendron-Fitzpatrick; Nirmala Ramanujam Journal: Lasers Surg Med Date: 2004 Impact factor: 4.025
Authors: Narasimhan Rajaram; Timothy J Aramil; Kelvin Lee; Jason S Reichenberg; Tri H Nguyen; James W Tunnell Journal: Appl Opt Date: 2010-01-10 Impact factor: 1.980